Skip Navigation

JNCI Journal of the National Cancer Institute 2006 98(10):670; doi:10.1093/jnci/djj222
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© Oxford University Press 2006.

NEWS

In Brief

The first 10% of the full text of this article appears below.

ER-Negative Breast Cancer Patients Benefit From Newer Chemotherapy

Newer chemotherapy treatments may reduce the risk of breast cancer recurrence for patients whose tumors lack estrogen receptors, a type traditionally considered more difficult to treat, a study reports.

Eric Winer, M.D., at the Dana-Farber Cancer Institute in Boston, and colleagues identified 6,600 breast cancer patients with estrogen receptors (ER positive) and without (ER negative) who had . . . [Full Text of this Article]

New Research Links High Cholesterol and Prostate Cancer

Early Onset of Colorectal Cancer Associated With Alcohol, Tobacco, and Men

Painkiller Stops Aromatase Production, May Fight Breast Cancer


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?